Mucinoses: Clinical Trials

54 trials for Mucinoses, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

54 completed. 54 Phase 2, 31 Phase 1, 7 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 254Completed 54
Phase 131Completed 31
Phase 37Completed 7

Follow Mucinoses: new trials by email Literature Review of Mucinoses trials Research Report on Mucinoses

Trials (filtered) newest first · largest first

All 54 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I)
JR-171 - Mucopolysaccharidosis I
Phase 1 / Phase 2CompletedJCR Pharmaceuticals Co., Ltd.142021-10-282025-08-28
RGX-121 Gene Therapy in Children 5 Years of Age and Over With MPS II (Hunter Syndrome)
RGX-121 - Mucopolysaccharidosis Type II (MPS II)
Phase 1 / Phase 2CompletedREGENXBIO Inc.62021-03-112025-01-28
A Study of JR-171 in Patients With Mucopolysaccharidosis I
JR-171 (lepunafusp alfa) - Mucopolysaccharidosis I
Phase 1 / Phase 2CompletedJCR Pharmaceuticals Co., Ltd.182020-09-012025-03-19
Efficacy and Safety of mAnnitol in Bowel Preparation During Elective Colonoscopy and Comparison With Moviprep®
Phase II: NTC015 low dose, Phase II: NTC015 medium dose, Phase II: NTC015 high dose - Elective Colonoscopy
Phase 2 / Phase 3CompletedNTC srl8862020-06-182025-12-08
Comparison of Thread Technique Versus Aspiration Plus Steroid Injection for Wrist Ganglion Recurrence
methyl prednisolone acetate, Silk suture - Ganglion Cyst
Phase 1 / Phase 2CompletedBenazir Bhutto Hospital, Rawalpindi602020-06-012025-01-24
Study of Infigratinib in Children With Achondroplasia
Infigratinib 0.016 mg/kg, Infigratinib 0.032 mg/kg, Infigratinib 0.064 mg/kg - Achondroplasia
Phase 2CompletedQED Therapeutics, a BridgeBio company842020-03-102025-10-22
Open-label Study of Anakinra in MPS III
anakinra - Mucopolysaccharidosis III
Phase 1 / Phase 2CompletedLynda E Polgreen242020-01-302024-10-22
A Study to Assess the Safety, Tolerability, and Efficacy of Long-term SOBI003 Treatment in Pediatric MPS IIIA Patients
SOBI003 - Sanfilippo Syndrome Type A (MPS IIIA)
Phase 1 / Phase 2CompletedSwedish Orphan Biovitrum62019-01-192022-02-25
A Study of JR-141 in Patients With Mucopolysaccharidosis II
JR-141 - Mucopolysaccharidosis II
Phase 2 / Phase 3CompletedJCR Pharmaceuticals Co., Ltd.282018-08-012022-11-14
A Study of JR-141 in Patients With Mucopolysaccharidosis II (BR21)
JR-141 - Mucopolysaccharidosis II
Phase 2CompletedJCR Pharmaceuticals Co., Ltd.182018-07-262025-07-24
A Study to Assess the Safety and Tolerability of SOBI003 in Pediatric MPS IIIA Patients
SOBI003 - Sanfilippo Syndrome Type A (MPS IIIA)
Phase 1 / Phase 2CompletedSwedish Orphan Biovitrum62018-06-192021-11-19
Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation
Thiotepa--single daily dose, Thiotepa--escalated dose - Bone Marrow Failure Syndrome, Thalassemia
Phase 1 / Phase 2CompletedUniversity of Florida62018-06-152023-09-15
MGTA-456 in Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
MGTA-456 - Inherited Metabolic Disorders (IMD)
Phase 2CompletedMagenta Therapeutics, Inc.82018-02-092021-11-03
S 81694 Plus Paclitaxel in Metastatic Breast Cancer
Combination therapy (S81694 + paclitaxel) phase I, Paclitaxel, Combination therapy (S81694 + paclitaxel) phase II - Metastatic Breast Cancer, Metastatic Triple Negative Breast Cancer
Phase 1 / Phase 2CompletedInstitut de Recherches Internationales Servier222018-01-042021-05-25
A Study in MPS VI to Assess Safety and Efficacy of Odiparcil
Odiparcil, Placebo - Mucopolysaccharidosis VI
Phase 2CompletedInventiva Pharma202017-12-302019-11-01
Gene Therapy in Patients With Mucopolysaccharidosis Disease
AAV2/8.TBG.hARSB - Mucopolysaccharidosis Type VI
Phase 1 / Phase 2CompletedFondazione Telethon92017-07-172024-11-22
Ibuprofen Plus Acetaminophen Versus Oxycodone Alone After Hand Surgery
Oxycodone Hcl 5Mg, Ibuprofen 400 mg, Acetaminophen 650 mg - Carpal Tunnel Syndrome, Dupuytren Contracture
Phase 2CompletedUniversity of Southern California402017-04-242019-09-26
Botulinum Toxin Type A Block of the Otic Ganglion in Chronic Cluster Headache: Safety Issues
Botulinum Toxin Type A 25 IU, Botulinum Toxin Type A 12.5 IU - Cluster Headache
Phase 1 / Phase 2CompletedNorwegian University of Science and Technology102017-04-182021-06-23
A Study of JR-141 in Patients With Mucopolysaccharidosis Type II
JR-141 - Mucopolysaccharidosis II
Phase 1 / Phase 2CompletedJCR Pharmaceuticals Co., Ltd.142017-03-302022-11-14
A Study to Evaluate OPTI-BIOME™ Bacillus Subtilis MB40 on Abdominal Discomfort, Gas and Bloating in a Healthy Population
OPTI-BIOME™ Bacillus subtilis MB40, Placebo - Bloating
Phase 2CompletedBIO-CAT Microbials, LLC1002016-10-012021-10-29

Showing 20 of 54. Sign in to see all of them.

Narrower conditions

Mucopolysaccharidosis II (15)  ·  Mucopolysaccharidosis I (14)  ·  Lysosomal Storage Diseases (11)  ·  Mucopolysaccharidosis III (11)  ·  Mucopolysaccharidosis IV (9)  ·  Mucopolysaccharidoses (8)  ·  Sudden Infant Death (7)  ·  Mucopolysaccharidosis VI (6)  ·  Genetic Diseases, Inborn (5)  ·  Metabolic Diseases (5)  ·  Metabolism, Inborn Errors (4)  ·  Adrenoleukodystrophy (3)  ·  Ganglion Cysts (3)  ·  Leukodystrophy, Globoid Cell (3)  ·  Leukodystrophy, Metachromatic (3)

Broader conditions

Skin and Connective Tissue Diseases (54)  ·  Connective Tissue Diseases (53)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (51)  ·  Nutritional and Metabolic Diseases (51)  ·  Carbohydrate Metabolism, Inborn Errors (50)  ·  Metabolism, Inborn Errors (47)  ·  Genetic Diseases, Inborn (46)  ·  Metabolic Diseases (46)  ·  Mucopolysaccharidoses (43)  ·  Lysosomal Storage Diseases (40)  ·  Nervous System Diseases (25)  ·  Neurologic Manifestations (20)  ·  Genetic Diseases, X-Linked (18)  ·  Pathological Conditions, Signs and Symptoms (18)

Interventions

idursulfase (4)  ·  Iduronidase (3)  ·  Stem Cell Transplantation (3)  ·  Alemtuzumab (2)  ·  Busulfan (2)  ·  Cyclophosphamide (2)  ·  Cyclosporine (2)  ·  GALNS protein, human (2)  ·  Hematopoietic Stem Cell Transplantation (2)  ·  valanafusp alpha (2)  ·  Acetaminophen (1)  ·  Adalimumab (1)  ·  Azathioprine (1)  ·  Bone Marrow Transplantation (1)  ·  Botulinum Toxins, Type A (1)

Sponsors

Shire (7)  ·  JCR Pharmaceuticals Co., Ltd. (5)  ·  Masonic Cancer Center, University of Minnesota (4)  ·  BioMarin Pharmaceutical (3)  ·  ArmaGen, Inc (2)  ·  Genzyme, a Sanofi Company (2)  ·  LYSOGENE (2)  ·  Swedish Orphan Biovitrum (2)  ·  The Canadian College of Naturopathic Medicine (2)  ·  Ultragenyx Pharmaceutical Inc (2)  ·  Alexion Pharmaceuticals, Inc. (1)  ·  Allievex Corporation (1)  ·  BIO-CAT Microbials, LLC (1)  ·  Benazir Bhutto Hospital, Rawalpindi (1)  ·  Children's Hospital Los Angeles (1)

Countries

United States (30)  ·  United Kingdom (16)  ·  France (13)  ·  Canada (9)  ·  Brazil (8)  ·  Germany (8)  ·  Spain (8)  ·  Italy (5)  ·  Japan (5)  ·  Netherlands (4)  ·  Turkey (Türkiye) (4)  ·  Australia (3)  ·  Mexico (2)  ·  Portugal (2)  ·  Russia (2)

Top investigators

Paul Orchard, MD (4)  ·  Dugald Seely, ND (2)  ·  Patrice P Rioux, MD PhD (2)  ·  Paul Harmatz, MD (2)  ·  Abdul Basit, MBBS, FCPS (1)  ·  Alidad Ghiassi, MD (1)  ·  Biljana Horn, MD (1)  ·  Celeste Decker, MD (1)  ·  Chester B. Whitley (1)  ·  Chris D'Adamo, PhD (1)  ·  Debra Lounsbury (1)

Results publications

PMID 29976218, PMID 30467742, PMID 35835061, PMID 35961250, PMID 37915038, PMID 21150784, PMID 21586746, PMID 22547151, PMID 22929184, PMID 23497636, PMID 23837440, PMID 25323764, PMID 25421091, PMID 26331768, PMID 27211612, PMID 28119821, PMID 29526614, PMID 30528227, PMID 30595526, PMID 31719214, PMID 32583902, PMID 33874971, PMID 34040605, PMID 35331634, PMID 35342457, PMID 35588317, PMID 35709957, PMID 36027721, PMID 36413418, PMID 36799346, PMID 37415957, PMID 38204164, PMID 38319253, PMID 38907160, PMID 39547230, PMID 39555818, PMID 40786127

NIH funding

2004 (1), 2009 (1), 2014 (1), 2015 (1), 2016 (1), 2017 (1), 2019 (1)